HERON THERAPEUTICS, INC. /DE/ — Director's Dealing 2012

Aug 9, 2012

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: AP PHARMA INC /DE/ (APPA)
CIK: 0000818033
Period of Report: 2012-07-30

Reporting Person: Rosen Robert (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Non-Qualified Stock Option (right to buy)	$.66	2022-07-30	Common Stock (1000000)		Direct
Non-Qualified Stock Option (right to buy)	$.66	2022-07-30	Common Stock (500000)		Direct

Footnotes

F1: Options will vest with respect to 1/36 of the underlying shares monthly so that the options are fully vested on the third anniversary of the date of grant.

F2: Options will vest with respect to 1/12 of the underlying shares monthly so that the options are fully vested one year from the date of grant.